Patent Assignment
Reel/Frame 048500/0865
Certificate of Conversion
Recorded: 2019-03-05
Pages: 9
Assignor
AROG PHARMACEUTICALS, LLC
Executed: 2014-09-13
Assignee
AROG PHARMACEUTICALS, INC.
5420 LBJ FREEWAY, STE. 410, TWO LINCOLN CENTRE, DALLAS, TEXAS, 75240
Covered Properties
(2)
Crenolanib for Treating FLT3 Mutated Proliferative Disorders
Method of Inhibiting Mutant C-Kit
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.